| Darmawai Salley, LPN | |
|
6040 Southport Dr, Bethesda, MD 20814-1848 | |
| (301) 493-4200 | |
| (301) 493-6209 |
| Full Name | Darmawai Salley |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 6040 Southport Dr, Bethesda, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598192809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LP47814 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darmawai Salley, LPN 6040 Southport Dr, Bethesda, MD 20814-1848 Ph: (301) 493-4200 | Darmawai Salley, LPN 6040 Southport Dr, Bethesda, MD 20814-1848 Ph: (301) 493-4200 |
News Archive
The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms worsen and then improve.
Mike Gittelman, MD, Co-Director, Comprehensive Children's Injury Center and the experts at Cincinnati Children's Hospital Medical Center want to make sure that families and children stay safe while playing outdoors this summer.
Research into why some people react badly to certain medicines has received £4m from the government.
BioDelivery Sciences International, Inc. announced today that its abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain. The presentation will take place on Friday, September 10, as part of the 7:00 - 9:00 AM podium presentation session.
Ascend Biopharmaceuticals today announces that is has entered into an agreement with 3M Drug Delivery Systems to evaluate 3M's Toll-Like Receptor 7/8 (TLR7/8) agonist 3M-051 in combination with Ascend's proprietary cancer vaccine technology. The collaboration will support the creation and preclinical assessment of novel immunotherapy treatments to be potentially used for a number of different solid tumor types.
› Verified 6 days ago
Mrs. Jennifer Ekundayo Jackson-bickersteth, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Southport Dr, Bethesda, MD 20814 Phone: 301-715-3673 Fax: 888-496-8354 | |
Deborah Wallace, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Southport Dr, Bethesda, MD 20814 Phone: 301-493-4200 | |
Armene S Michel, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-6672 | |
Latoya Woodroffe, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Southport Dr, Bethesda, MD 20814 Phone: 301-493-4200 Fax: 301-493-6209 | |
Yvonne Medina, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Southport Dr, Bethesda, MD 20814 Phone: 301-493-4200 Fax: 301-493-6209 |